It is “still too early to tell” how a post COVID-19 pandemic consumer environment will look like, says Blackmores, which has seen a mixture of gains and losses across Asia-Pacific in its latest financial results.
Nestle’s strategy to focus on product affordability and accessibility appears to have paid off in 2022, with the firm seeing more significant growth from its business in emerging markets even amid inflationary and economic turbulence.
Beverage giant Vitasoy believes that oat milk is set to be an important avenue of growth for the company across multiple APAC markets including China, Oceania and the Philippines.
Hindustan Unilever Limited (HUL), the company’s India arm, has attributed its move to reduce tea prices to its successful ‘Winning in Many Indias’ business model as well as a rare drop in commodity pricing for tea.
China dairy giant Yili has registered record growth and increased market share in its recently-released H1FY2022 financial report, and has attributed this success to the sales of its value-added dairy products as well as its efforts in rapid new product...
ASX-listed Australian firm McPherson’s has reported almost 90 per cent annual growth in its health business in FY22, with the herbals brand Fusion – previously owned by Blackmores’ Global Therapeutics – performing particularly well.
China’s largest vitamin and dietary supplement (VDS) firm BYHEALTH is reaping the benefits of an expanding domestic market, as it reported yet another record year of profit and revenue growth.
Infant formula maker Bubs reported a record high gross revenue coming from corporate daigou companies, which help individual sellers navigate hurdles such as procurement and deliveries.
Nestle’s recent half-year financial results report revealed slower growth in APAC compared to its other operating regions due to continuing economic difficulties and likely local struggles with the COVID-19 pandemic.
